C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 385-392

  Reddy, Madhava C ^a   Subhashini, J ^a   Mahipal, S V K ^a   Bhat, Vadiraja B ^c   Reddy, P Srinivas ^a   Kiranmai, G ^a   Madyastha, K M ^b   Reddanna, P ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Apoptosis; C Phycocyanin; Cyclooxygenase 2; Cytochrome c; RAW 264.7 cells

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; C PHYCOCYANIN; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME C; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYCOCYANIN; PROSTAGLANDIN E2; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL NUCLEUS; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; FRAGMENTATION REACTION; MACROPHAGE; MACROPHAGE ACTIVATION; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS;

ALGAE; CHLOROPHYTA; CYANOBACTERIA; SPIRULINA; SPIRULINA PLATENSIS; UNCULTURED CYANOBACTERIUM;

EID: 0037414468     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00586-2     Document Type: Article

References (43)

1. Vadiraja B.B., Gaikwad N.W., Madyastha K.M. Hepatoprotective effect of C-Phycocaynin: protection for carbon tetrachloride and R-(+)-pulegone mediated hepatotoxicity in rats. Biochem. Biophys. Res. Commun. 249:1998;428-431.
2. Bhat V.B., Madyastha K.M. C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro. Biochem. Biophys. Res. Commun. 275:2000;20-25.
3. Remirez D., Gonzalez A., Merino N., Gonzalez R., Ancheta O., Romay C., Rodriguez S. Effect of Phycocyanin in zymosan-induced arthritis in mice-Phycocyanin as an antiarthritic compound. Drug. Dev. Res. 48:1999;70-75.
4. 2 levels in mouse ear inflammation test Arzneimittelforschung. 50:2000;1106-1109.
5. Romay C., Armesto J., Remirez D., Gonzalez R., Ledon N., Garcis I. Antioxidant and anti-inflammatory properties of C-Phycocyanin from blue green algae. Inflamm. Res. 47:1998;36-41.
6. Reddy C.M., Vadiraja B.B., Kiranmai G., Reddy M.N., Reddanna P., Madyastha K.M. Selective inhibition of cyclooxygenase-2 by C-Phycocyanin, a biliprotein from Spirulina platensis. Biochem. Biophys. Res. Commun. 277:2000;599-603.
7. Vane J.R., Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J. 1:1987;89-96.
8. Smith W.L. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 263:1992;F181-F191.
9. Whittle B.J., Higgs G.A., Eakins K.E., Moncada S., Vane J.R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature. 284:1980;271-273.
10. Mocanda S., Gryglewski R., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 263:1976;663-665.
11. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandinsynthase/cyclooxygenase homologue. J. Biol. Chem. 266:1991;12866-12872.
12. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88:1991;2692-2696.
13. Dannenberg A.J., Altorki N.K., Boyle J.O., Dang C., Howe L.R., Weksler B.B., Subbaramaiah K. Cyclo-oxygenase 2: a pharmaceutical target for the prevention of cancer. Lancet Oncol. 2:2001;544-551.
14. DuBois R.N., Radhika A., Reddy B.S., Estingh A.J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1996;1259-1262.
15. Campling B.G., Pym J., Galbraith P.R., Close S.P. Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leukemia Res. 12:1988;823-831.
16. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C.A. Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
17. Shah G.M., Shah R.G., Poirier G.G. Different cleavage pattern of poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun. 229:1996;838-844.
18. Liu X.H., Yao S., Kirschenbaum A., Levine A.C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58:1998;4245-4249.
19. 2 in human colon cancer cells Cancer Res. 58:1998;362-366.
20. Lui X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
21. Martinou J.C., Desagher S., Antonsson B. Cytochrome c release from mitochondria: all or nothing. Nat. Cell Biol. 2:2000;E41-E43.
22. 2 . Distinct roles of cyclooxygenase-1 and -2 J. Biol. Chem. 272:1997;25693-25699.
23. DeWitt D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1083:1991;121-134.
24. Smith W.L., Marnett L.J. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta. 1083:1991;1-17.
25. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:1992;25934-25938.
26. Kune G.A., Kune S., Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48:1988;4399-4404.
27. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., Willett W.C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121:1994;241-246.
28. Gupta R.A., DuBois R.N. Aspirin, NSAIDs and colon cancer prevention: mechanisms? Gastroenterology. 114:1998;1095-1098.
29. Hall P.A., Coates P.J., Ansari B., Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell Sci. 107:1994;3569-3577.
30. Bedi A., Pasricha P.J., Akthar A.J., Barber J.P., Bedi G.C., Giardiello F.M., Zehnbauer B.A., Hamilton S.R., Jones R.J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1995;1811-1816.
31. Fournier D.B., Gordon G.B. COX-2 and colon cancer: potential targets for chemoprevention. J. Cell. Biochem. 77:2000;97-102.
32. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620.
33. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
34. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;14681-14686.
35. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsuda H., Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. USA. 95:1998;1455-1459.
36. Hsu A.L., Ching T.T., Wang D.S., Song X., Rangnekar V.M., Chen C.S. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 275:2000;11397-11403.
37. Patti R., Gumired K., Reddanna P., Sutton L.N., Phillips P.C., Reddy C.D. Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib. Cancer Lett. 180:2002;13-21.
38. Li M., Wu X., Xu X.C. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin. Cancer Res. 7:2001;1010-1016.
39. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
40. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP- ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
41. +2 -dependent endonuclease activity by nicotinamide adenine dinucleotide and poly(adenosine diphosphate ribose) synthetase Biochem. Biophys. Res. Commun. 59:1974;658-665.
42. 2+ -dependent endonuclease Proc. Natl. Acad. Sci. USA. 72:1975;289-293.
43. 2+ -dependent endonucleases of bull seminal plasma induced by ADP-ribosylation J. Biol. Chem. 25(9):1984;6579-6585.